GENOCEA BIOSCIENCES, INC. — Net Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d4a37e13-3164-47da-810a-c23e234c2c6d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-33.2M | 2021-01-01 – 2021-12-31 | evidence 0001457612-22-000039 |
| FY 2020 | $-43.7M | 2020-01-01 – 2020-12-31 | evidence 0001457612-21-000022 |
| FY 2019 | $-39.0M | 2019-01-01 – 2019-12-31 | evidence 0001457612-20-000015 |
| FY 2018 | $-27.8M | 2018-01-01 – 2018-12-31 | evidence 0001457612-19-000027 |
| FY 2017 | $-56.7M | 2017-01-01 – 2017-12-31 | evidence 0001457612-18-000019 |
| FY 2016 | $-49.6M | 2016-01-01 – 2016-12-31 | evidence 0001457612-17-000009 |
| FY 2015 | $-42.5M | 2015-01-01 – 2015-12-31 | evidence 0001457612-16-000048 |
| FY 2014 | $-35.3M | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-014851 |
| FY 2013 | $-83.4M | 2006-08-16 – 2014-03-31 | evidence 0001104659-14-036982 |
| FY 2012 | $-13.4M | 2012-01-01 – 2012-12-31 | evidence 0001104659-15-014851 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GENOCEA BIOSCIENCES, INC. — all facts · Revenue · Operating Income